Shenzhen Anke

Shenzhen Anke High-tech Co., Ltd. stands as one of China’s earliest high-tech medical device enterprises, established in 1986 as a Sino-US joint venture between the Chinese Academy of Sciences and Analogic Corporation (NASDAQ-listed). Over nearly four decades, the company has accumulated deep expertise in medical imaging equipment including CT, MRI, and X-ray systems, while expanding into neurosurgical navigation and minimally invasive treatment devices.

Company Overview

Founded during China’s early push to develop indigenous medical technology capabilities, Shenzhen Anke emerged from a collaboration between Chinese academic institutions and American industrial expertise. The company is headquartered in Bao’an District, Shenzhen, Guangdong Province, and maintains a national-level postdoctoral research station.

Anke holds certifications including ISO 13485 and ISO 9001 quality management systems, with products approved by NMPA (formerly SFDA), CE Mark, and FDA. The company has established sales and service networks throughout China and internationally, serving a customer base exceeding 10,000 hospitals.

As of 2023, Anke held 214 patents, with invention patents comprising approximately 50% of its portfolio. The company has been recognized as a Guangdong Province Intellectual Property Advantage Enterprise and a Shenzhen “Little Giant” Specialized and New Enterprise.

Core Products

Medical Imaging Systems

Anke’s primary business encompasses large-scale medical imaging equipment:

MRI Systems: The company developed China’s first permanent magnet MRI (1989), first superconducting MRI (1992), and first open permanent magnet MRI (1998). Current product lines cover various field strengths for different clinical applications.

CT Systems: Anke manufactures spiral CT scanners for diagnostic imaging, including mobile CT solutions for emergency medical response scenarios.

X-ray Systems: Digital radiography systems for general diagnostic imaging applications.

Neurosurgical Navigation System

In 2000, Anke developed China’s first neurosurgical navigation system, marking an early entry into surgical guidance technology. This system provides image-guided surgical planning and intraoperative navigation for neurosurgical procedures.

The neurosurgical navigation platform builds on Anke’s imaging expertise to offer:

• Preoperative surgical planning based on CT/MRI data
• Real-time instrument tracking during surgery
• Multi-modality image fusion capabilities

Emerging Developments

Building on its foundation in neurosurgical navigation, Anke has been developing advanced cranial surgery robotic systems. The company’s experience with surgical navigation technology and medical imaging provides a technical foundation for robotic surgical assistance applications.

Technology & Innovation

Anke’s technical capabilities center on medical imaging acquisition and processing:

Imaging Technologies: The company has developed proprietary perfusion imaging and angiography techniques, providing clinicians with diagnostic information for various clinical scenarios.

Software Platforms: Anke operates medical informatics solutions including PACS (Picture Archiving and Communication System), which the company pioneered in China in 1995.

Integration Capabilities: The company’s experience spanning imaging hardware, navigation software, and clinical workflow integration positions it to develop broad surgical assistance solutions.

Market Presence

Anke serves over 10,000 hospitals across China, with particular strength in:

• Secondary and tertiary hospitals requiring cost-effective imaging solutions
• Mobile medical imaging for emergency response applications
• Regional markets where domestic equipment offers advantages in service and support

The company has established presence in international markets through CE and FDA certifications, though its primary focus remains the Chinese domestic market.

Key Milestones

• 1986: Company established as Sino-US joint venture
• 1989: Developed China’s first MRI system
• 1990: Developed China’s first color Doppler ultrasound system
• 1991: Became first high-tech enterprise in Chinese medical device industry
• 1992: Developed China’s first superconducting MRI (named one of China’s top 10 scientific achievements)
• 1994: Ranked among National Top 100 High-tech Enterprises
• 1995: Developed China’s first PACS
• 1996: Established one of China’s earliest enterprise-based postdoctoral workstations
• 1998: Developed China’s first open permanent magnet MRI
• 2000: Developed China’s first neurosurgical navigation system
• 2023: Withdrew ChiNext IPO application

Frequently Asked Questions

What products does Shenzhen Anke manufacture?

Anke primarily manufactures medical imaging equipment including MRI systems, CT scanners, and X-ray systems. The company also develops neurosurgical navigation systems and medical informatics solutions such as PACS. Anke has been expanding into surgical robotics building on its navigation technology expertise.

Is Shenzhen Anke a publicly traded company?

As of 2026, Shenzhen Anke is not publicly traded. The company submitted an IPO application for the ChiNext board in 2022 but withdrew the application in June 2023. The company operates as a Sino-US joint venture between the Chinese Academy of Sciences and Analogic Corporation.

What certifications does Shenzhen Anke hold?

Anke products are certified under ISO 13485 and ISO 9001 quality management systems. The company holds NMPA registration for the Chinese market, CE Mark for European markets, and FDA clearance for select products in the United States.